Skinny, Inc. Part 1: the Canadian connection to Ozempic
This episode explores the Canadian connection to the drug Ozempic, detailing Dr. Daniel Drucker's decades of research on semaglutide, inspired partly by a lizard. It also addresses rising obesity in Canada with insights from a doctor and a patient using GLP-1 medications.